Carbon nanotubules may have future role in DBS

New research is published showing that carbon nanotubules which are highly electrically conductive form extremely tight contacts with neuronal cell membranes. Carbon nano-electrodes could also be used to replace metal parts in clinical applications such as deep brain stimulation for the treatment of Parkinson's disease or severe depression. And they show promise as a whole new class of "smart" materials for use in a wide range of potential neuroprosthetic applications. Read more.

Fox Foundation launching “PD Online Reseach”

The Michael J Fox Foundation has announced plans to launch “PD Online Research”. The Foundation describes the site as “the future home of a new web community of scientists, industry professionals, grant makers and financial investors dedicated to advancing the treatment, prevention, and cure of Parkinson's disease” and promises that the “PD Online Research community will work to build a sophisticated and continuously updated knowledge base of Parkinson's disease, and to actively guide research funding and investment through interaction with funders and financial investors”.
The site is currently in development and due to launch in the spring 2009 but is already seeking applications for membership. Click to here apply.

December PDtrials Newsletter

PDtrials Parkinson’s Clinical Research December 2008 Newsletter is now available. This edition features two new clinical trials (both beginning in the USA). The first study, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS) will evaluate the therapeutic potential of transcranial magnetic stimulation (TMS) on symptoms of Parkinson’s Disease. People with mild to moderately severe PD who are between 40 and 80 years of age and whose main problems are slow movement and stiffness may be eligible for this study. The second study, sponsored by Department of Veterans Affairs, Rehabilitation Research and Development; University of Iowa, will examine the effects of aerobic exercise in motor and cognitive function in patients with Parkinson’s disease.
Also covered in this issue are:
* New Clinical Trials
* PDtrials Announces an Educational Webinar
* Older Antidepressants Work for Parkinson's Patients
* Pesticide Exposure Boosts Parkinson's Risk by 60 Percent
* Ceregene Therapy for Parkinson's Fails Phase II Trial
* New Longevity Drugs Poised to Tackle Diseases of Aging
* Schering-Plough's Phase II Parkinson's Trial Meets Primary Endpoint
* New Research Helps Explain Genetics of PD
Subscription to the free electronic newsletter is available here.

Curry ingredient may slow Parkinson's Disease

Researchers at Johns Hopkins Medicine have found that curcumin, the spice used in curries, reduces inflammation and oxidative damage to brain cells which has been implicated in Parkinson’s disease. More information here.